Europe Compression Therapy Market

Europe Compression Therapy Market Size (2022 to 2027)

The European compression therapy market size is forecasted to be growing at a prominent CAGR of 4.6% from 2022 to 2027.

The application of compression therapy devices to treat various ailments such as varicose veins, lymphedema, leg ulcer, and deep vein thrombosis creates an irreplaceable position for these products in medical treatment areas. According to a recently published article, varicose vein disease affects up to 4 in 10 adults. In addition, varicose veins are more common in women and the geriatric population and affect around 23 million women between the ages of 40 and 80. Patients with varicose veins are recommended to undergo compression therapy for six months and graduated compression stockings are widely used as the first-line treatment for varicose veins.

The ease of use and the high efficacy of the treatment increase the popularity of these products in the medical field. The availability of patient-friendly compressions therapy garments such as compression bandages and bandages and compression stockings are helping the market grow. Increasing R&D activities by manufacturers of these garments to make their products available in a variety of designs and easy to use for treating trauma or pain management is driving the market's growth. In addition, clinical evidence that supports compression therapy options for some disease treatment and advancement in orthopedic surgeries will help market growth.

Healthcare organizations are taking initiatives to promote awareness of the use of compression therapy and promote compression therapy products. This is likely to develop opportunities for market growth. For example, the FDA classifies compression stockings as a device for general medical use as a Class I devise. The FDA performs this classification to exempt products from the FDA 510k pre-market notification requirements.

Limitations of Compression Therapy include the side effects caused by using these products, such as dry skin, itching, and slipping, which are likely to hamper the market's growth. Therefore, the European authorities hold test methods for medical compression garments and specify the requirements, including custom stockings used to treat venous & lymphatic diseases for lower limbs. This standard makes it possible to prescribe medical elastic compression stockings with a precise idea of ​​the quality of the compression for the benefit of the patients.

Additionally, elderly patients with co-morbidities find it difficult to use compression therapy products such as compression stockings, and lack of awareness about compression therapies amongst the population is hampering the market growth.

Impact of COVID-19 on the European compression therapy market:

The current COVID-19 pandemic is an unprecedented public health problem. COVID-19 hospital patients are recommended to stay in bed for an extended period of time. Therefore, immobility in these patients increases the risk of blood clots, leading to deep vein thrombosis (DVT). Additionally, pneumonia is one of the main complications of COVID-19 disease and is also associated with venous thromboembolism (VTE). Therefore, compression therapy is recommended. However, product manufacturing and distribution caused disruptions and has hampered the market slightly.

This research report on the European compression therapy market has been segmented and sub-segmented based on the following categories:

By Product:

• Garments
  • Stockings
  • Bandages & Wraps
  • Other Garments
• Braces
• Pumps

By Technique:

• Static
• Dynamic

By Application:

• Varicose Vein Treatments
• Deep Vein Thrombosis Treatments
• Lymphedema Treatments
• Leg Ulcer Treatments
• Others

By Distribution Channel:

• Pharmacies & Retailers
• Hospitals & Clinics
• E-Commerce Platforms

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Regional Analysis:

Geographically, the German compression therapy market dominates the European market due to the significant sale of compression therapy devices. Further, factors such as the high adoption rate of these products, the presence of obese patients, and the prevalence of chronic venous disorders drive the market growth in this region. In addition, the region was a dominant market share due to the presence of major manufacturers in the region. According to the NCBI, Western countries reported the highest number of chronic venous disorders (12 to 18% in men and 14.9 to 41% in women). Besides, the market in the United Kingdom is expected to grow in the coming years, in terms of demand, due to the growing health concerns and the penetration of international brands in this region.

KEY MARKET PARTICIPANTS:

Companies such as Medi GmbH & Co., Medtronic Plc, Julius Zorn GmbH, SIGVARIS, Hartmann AG, BSN Medical GmbH, ArjoHuntleigh, 3M Health Care, Spectrum Healthcare, Bio Compression Systems, Inc., and Gottfried Medical are a few of the noteworthy companies operating in the European compression therapy market.